ACTL6A and cancer: Our analysis of genomic profiling of several cancer types in TCGA demonstrated that ACTL6A gene is amplified in 26.73% of ovarian cancer (Fig. 1a) and the amplification is the most common genetic event of ACTL6A in ovarian cancer (Fig. 1b).